Cronos Group Inc (CRON)
$6.27 0.18 (2.79%)
19:55 EDT CRON Stock Quote Delayed 30 Minutes
Previous Close $6.27
Market Cap 1.10B
PE Ratio -
Volume (Avg. Vol.) 2.59M
Day's Range 6.24 - 6.48
52-Week Range 4.00 - 15.85
Dividend & Yield N/A (N/A)
CRON Stock Predictions, Articles, and Cronos Group Inc News
- From InvestorPlace
- From the Web
Under conventional thinking, CRON stock can’t reach its full potential without the U.S. fully legalizing weed. But the “dumbed-down” CBD market is really what the American consumer desires, which benefits Cronos via its Lord Jones acquisition.
By Ian Cooper
With plenty of demand and legalization efforts, the long-term growth story is still very much intact with Organigram stock.
The 2020 presidential election will be a fierce battle. Here are the stocks to buy, depending on who wins the White House.
As a high-quality pick in a resurgent cannabis sector, CRON stock could be due for big returns in calendar 2020.
Options trading was hot in Bristol-Myers Squibb, Cronos and Canopy Growth stock on Tuesday. Here’s what the data suggests moving forward.
Matt McCall predicts that 2020 will be a better year for U.S. cannabis stocks. He's also calling for a big rally in bitcoin.
It’s unlikely to be the next Netflix or Microsoft, but Canopy Growth stock has made the case for today’s investors to take a nibble
Cannabis stocks have taken a huge hit in 2019 and will likely remain volatile while the industry goes through its growing pains. Long-term cannabis bulls can consider mitigating their portfolio risk by going long top legal cannabis producers and short CBD-focused stocks.
The best stocks in the pot sector might be the medical marijuana plays. These 3 medical marijuana stocks should have big upside.
Pot stocks had a dark and depressing 2019, but 2020 could prove to a be much brighter year for this beaten-up group.
Although Cronos Group stock distinguishes itself in the embattled cannabis sector, it too makes some assumptions about future growth potential that may not suit all investors.
Cronos stock long has been the pot stock for investors who don't like pot stocks. That might be enough for a buy at some point.
With some recent bullish moves, Aurora Cannabis stock looks interesting as a contrarian trade. However, it has much to prove before anyone can offer a confident recommendation.
This morning, I am recommending a bearish trade on Cronos Group, Inc. (NASDAQ:CRON), the vertically integrated cannabis company.
CRON stock should become an eventual winner for investors, but the rally sparked by the vote in the U.S. House will likely not last.
From Market News Video
From Seeking Alpha
Navellier RatingsPowered by Portfolio Grader